The emerging approach of this peptide represents a significant development in the care of type 2 diabetes. Unlike existing drugs, tirzepatide targets multiple pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide366893.blog2news.com/42536372/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment